Starlight Therapeutics

About Starlight Therapeutics

Starlight Therapeutics is a precision oncology company focused on central nervous system cancers, with lead candidate STAR-001 aimed at glioblastoma, brain metastases, and pediatric CNS cancers. The company emphasizes AI-driven data insights and collaboration with leading cancer researchers to address unaddressed brain tumor indications. It operates globally, highlighting a focus on CNS oncology and therapies capable of crossing the blood-brain barrier to improve patient outcomes.